Sarah Kennedy: Calocurb CEO on the cost of weight loss drugs in the US versus NZ, long term use episode artwork

EPISODE · Aug 4, 2026 · 6 MIN

Sarah Kennedy: Calocurb CEO on the cost of weight loss drugs in the US versus NZ, long term use

from The Mike Hosking Breakfast · host Newstalk ZB

Weight loss drugs are reshaping the US retail landscape, but New Zealand is unlikely to see the same boom anytime soon.  GLP-1 medications are now being sold through major retailers like Costco and Walmart, with some costing as little as $25 a month.  Here, they can cost more than $400 a month, and have only been available for around a year, compared to five in the US.  Calocurb CEO Sarah Kennedy told Mike Hosking America is in a gold rush.  She says it's a way to acquire customers, because people will buy more at the retailers when getting their prescription.  LISTEN ABOVE See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Aug 4, 2026

Embed this episode

Ready to play

Sarah Kennedy: Calocurb CEO on the cost of weight loss drugs in the US versus NZ, long term use

0:00 6:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Mike Hosking Breakfast?

This episode is 6 minutes long.

When was this The Mike Hosking Breakfast episode published?

This episode was published on August 4, 2026.

Can I download this The Mike Hosking Breakfast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!